Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Hospital bed guidance comments

This article was originally published in The Gray Sheet

Executive Summary

FDA opts not to extend its Nov. 29 deadline for comments on its draft guidance "Hospital Bed System Dimensional Guidance to Reduce Entrapment," but asserts that if AdvaMed submits comments within 30 days of the deadline, they still will be considered in the preparation of the final guidance. AdvaMed had requested a 30-day extension Nov. 18 due to the high volume of input the trade organization received from member firms. FDA's Nov. 22 response asserts that a formal extension "is not necessary." The agency issued the draft guidance on Aug. 30, based on recommendations from a Hospital Bed Safety Workgroup (1"The Gray Sheet" Sept. 6, 2004, p. 21)...

Latest Headlines
See All
UsernamePublicRestriction

Register

MT021234

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel